29 studies found for:    HIV | tenofovir gel NOT gel capsules
Show Display Options
Rank Status Study
1 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
2 Completed Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Tenofovir gel placebo
3 Unknown  Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
Condition: HIV Prevention
Interventions: Drug: Tenofovir gel;   Drug: Universal placebo gel
4 Not yet recruiting Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
Condition: HIV Infections
Interventions: Drug: 1% tenofovir gel;   Drug: Placebo gel
5 Recruiting Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services
Condition: HIV
Intervention: Drug: 1% tenofovir gel
6 Completed Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir gel
7 Recruiting A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Condition: HIV
Interventions: Drug: 1% vaginally applied tenofovir gel;   Drug: Tenofovir film- 10mg;   Drug: Tenofovir Film-40 mg
8 Completed Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
Condition: HIV Infections
Intervention: Drug: Tenofovir gel
9 Completed Safety and Acceptability of a Vaginal Microbicide
Conditions: HIV Infections;   Hepatitis B, Chronic
Intervention: Drug: 1% tenofovir gel
10 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel
11 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
12 Recruiting Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel
Conditions: Pharmacokinetics of 1% Tenofovir Gel Following Coitus;   Pharmacodynamics of 1% Tenofovir Gel Following Coitus
Intervention: Drug: 1% Tenofovir Gel
13 Completed An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulation (VF) of tenofovir 1% gel;   Drug: Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel;   Radiation: Radiolabeling of study drugs and semen
14 Enrolling by invitation Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression
Condition: Antiretroviral Treatment Outcomes
Intervention: Drug: Tenofovir, lamivudine and efavirenz
15 Completed Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
Condition: Prevention
Intervention: Drug: Tenofovir 1% vaginal gel
16 Recruiting In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
17 Active, not recruiting Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel;   Drug: Depo-medroxyprogesterone acetate (DMPA);   Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
18 Active, not recruiting Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Condition: Herpes Simplex Type II
Interventions: Drug: Tenofovir;   Drug: placebo gel;   Drug: tenofovir disoproxil fumarate (TDF);   Drug: placebo tablets
19 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
20 Completed A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel;   Drug: Universal HEC Placebo Gel Formulation

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
Indicates status has not been verified in more than two years